Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis-Reference-Cited by-同舟云学术

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis

Published:2012-07 Issue:7 Volume:3 Page:e342-e342
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Delage B,Luong P,Maharaj L,O’Riain C,Syed N,Crook T,Hatzimichael E,Papoudou-Bai A,Mitchell T J,Whittaker S J,Cerio R,Gribben J,Lemoine N,Bomalaski J,Li C-F,Joel S,Fitzgibbon J,Chen L-T,Szlosarek P W

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis201283.pdf

Reference26 articles.

1. Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De Rosa V et al. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol 2004; 22: 1815–1822.

2. Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 2005; 23: 7660–7668.

3. Glazer ES, Piccirillo M, Albino V, Di Giacomo R, Palaia R, Mastro AA et al. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. J Clin Oncol 2010; 28: 2220–2226.

4. Yang TS, Lu SN, Chao Y, Sheen IS, Lin CC, Wang TE et al. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. Br J Cancer 2010; 103: 954–960.

5. Tennant DA, Duran RV, Gottlieb E . Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267–277.

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy;Cancer Letters;2024-08

2. Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes;Biochemical Pharmacology;2024-05

3. Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma;JAMA Oncology;2024-04-01

4. Pivotal Amino Acids Metabolism in the Progression of Leukemia;2024

5. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors;Frontiers in Oncology;2023-11-20